论文信息 - STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients - 字舞流文

STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients

R. Seethala | Lin Wang | R. Ferris | S. Ferrone | B. Branstetter | R. Srivastava | S. Trivedi | F. Concha-Benavente | Jie Hyun-Bae | Raghvendra M Srivastava